ERBB2 and breast carcinoma: Docetaxel-loaded TPGS liposomes have also been conjugated with the anti-human epidermal growth factor receptor 2 (HER2) monoclonal antibody, trastuzumab, which specifically binds to HER2-positive cancers such as breast cancers.